Tuesday, February 23, 2016

Longitudinal decline in mild-to-moderate Alzheimer’s disease: Analyses of placebo data from clinical trials

Accurate estimates of cognitive and clinical decline rates are essential to the design of clinical trials in Alzheimer’s disease (AD) dementia.

from Dementia Big http://ift.tt/1oywIZC
via Stopping Dementia



from WordPress http://ift.tt/1VBnuGY
via alcoholic dementia
http://ift.tt/1T3LcOy
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)